Lyon Joseph Douglas (CIK 1817838) reported 48 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-16). Recent activity: Buy CORT (2,596 shares), Buy CORT (7,404 shares), Sell CORT (7,812 shares), Sell CORT (2,188 shares), Buy CORT (130 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-16 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 2,596 | $29,465 |
| 2026-09-16 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 7,404 | $100,398 |
| 2026-09-16 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 7,812 | $885,261 |
| 2026-09-16 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 2,188 | $249,686 |
| 2026-09-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 130 | $14,739 |
| 2026-09-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 130 | $0 |
| 2026-09-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 72 | $8,163 |
| 2026-08-05 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 1,540 | $175,806 |
| 2026-06-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 537 | $37,826 |
| 2026-06-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 537 | $0 |
| 2026-06-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 269 | $18,948 |
| 2026-05-29 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 5,000 | $325,000 |
| 2026-03-04 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 398 | $14,316 |
| 2026-03-04 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 398 | $0 |
| 2026-03-04 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 89 | $3,201 |
| 2025-12-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 5,000 | $67,800 |
| 2025-12-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 5,000 | $397,650 |
| 2025-12-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 178 | $14,201 |
| 2025-12-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 178 | $0 |
| 2025-12-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 110 | $8,776 |
| 2025-11-05 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 5,000 | $67,800 |
| 2025-11-05 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 5,000 | $368,250 |
| 2025-10-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Buy | 5,000 | $67,800 |
| 2025-10-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 927 | $77,599 |
| 2025-10-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Accounting & Technology Officer | Sell | 3,473 | $294,927 |
来源：SEC Form 4 申报文件 · 截至 2026-09-16